ArticleTropical animal health and production2026
Repurposing of non-steroidal anti-inflammatory drugs as adjunct therapies against biofilm-forming Staphylococcus aureus isolated from camel milk.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of antimicrobial resistance (AMR) due to biofilm-forming S. aureus is a worldwide issue associated with a variety of persistent infections, including mastitis. This study investigated the prevalence and molecular characterization of biofilm-forming S. aureus, risk factors associated with subclinical mastitis (SCM), and simulation-based computational modeling for biofilm-associated protein. Moreover, repurposing of non-steroidal anti-inflammatory drugs as adjunct therapies against biofilm-forming S. aureus was investigated in combination with antibiotics. Overall, 384 camel milk samples were collected and subjected to the California mastitis test (CMT), and 51.30% SCM prevalence was found in sampled animals. Among these, 59.39% of SCM-positive milk isolates were positive for S. aureus, while the prevalence of staphylococcal biofilm-positive isolates by Congo red agar (CRA) and tube method was 41.88% and 31.6%, respectively. Further, on genotypic investigation, 47.86% and 31.62% of isolates were found to have icaA and icaD genes, respectively. After this, biofilm-forming isolates were subjected to phylogenetic assessment, and results exhibited strong sequence identity of local icaA and icaD isolates with neighbouring countries. Moreover, phylogenetic analysis was further validated with simulation-based computational modeling by using different tools, and results depicted a close evolutionary relationship and predominant structural integrity of the icaA protein. Drug susceptibility profiling of biofilm-positive isolates showed high resistance against amoxicillin, trimethoprim+sulphamethoxazole, and cefixime. Furthermore, In-Vitro combination therapy trials showed synergistic effect of amoxicillin and trimethoprim+sulphamethoxazole with flunixin meglumine and cefixime with meloxicam. This study will provide baseline data on biofilm-forming S. aureus persistence in the camel population, along with devising an effective therapy against biofilm-forming S. aureus infections.
Indexed as
Identifiers
42754789What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.